Application of Esketamine in Anesthesia of Autism Children

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Autism Spectrum Disorder
Interventions
DRUG

propofol combined with esketamine

In group PE, esketamine was firstly administered at a dose of 0.3 mg.kg-1, followed immediately by propofol with a single intravenous dose of 2.0 mg.kg-1.

DRUG

propofol-sufentanil

In group PS, sufentanil was administered intravenously at a dose of 0.2 μg.kg-1, then 2.0 mg.kg-1 propofol was intravenously injected.

Trial Locations (1)

Unknown

Sir Run Run Hospital, Nanjing

Sponsors
All Listed Sponsors
collaborator

Nanjing Medical University

OTHER

lead

The Second Hospital of Nanjing Medical University

OTHER

NCT05960942 - Application of Esketamine in Anesthesia of Autism Children | Biotech Hunter | Biotech Hunter